Maria Rivas Purchases 1,000 Shares of Cooper Companies (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) Director Maria Rivas acquired 1,000 shares of the firm’s stock in a transaction on Thursday, December 18th. The shares were bought at an average price of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the transaction, the director owned 11,141 shares of the company’s stock, valued at approximately $915,010.33. This trade represents a 9.86% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Cooper Companies Trading Up 0.4%

Shares of NASDAQ:COO traded up $0.29 during trading hours on Friday, hitting $82.75. 3,561,438 shares of the company’s stock traded hands, compared to its average volume of 2,478,541. The business has a fifty day moving average price of $74.41 and a 200-day moving average price of $71.89. The firm has a market capitalization of $16.22 billion, a P/E ratio of 44.02, a price-to-earnings-growth ratio of 2.35 and a beta of 1.05. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The Cooper Companies, Inc. has a 1 year low of $61.78 and a 1 year high of $100.24.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the company earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

COO has been the topic of a number of recent research reports. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Wells Fargo & Company raised their target price on shares of Cooper Companies from $72.00 to $82.00 and gave the company an “equal weight” rating in a research report on Friday, December 5th. Piper Sandler reaffirmed an “overweight” rating and issued a $94.00 price target (up previously from $83.00) on shares of Cooper Companies in a research report on Friday, December 5th. Weiss Ratings reissued a “sell (d+)” rating on shares of Cooper Companies in a report on Monday. Finally, Robert W. Baird upped their target price on Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a report on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of “Moderate Buy” and an average target price of $90.15.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds and other institutional investors have recently bought and sold shares of COO. Wealth Alliance LLC lifted its holdings in Cooper Companies by 4.2% in the second quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock valued at $301,000 after acquiring an additional 171 shares during the last quarter. Mesirow Financial Investment Management Inc. lifted its stake in shares of Cooper Companies by 1.3% in the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after purchasing an additional 175 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Cooper Companies by 0.8% during the 3rd quarter. Pacer Advisors Inc. now owns 23,079 shares of the medical device company’s stock worth $1,582,000 after purchasing an additional 182 shares during the last quarter. Citizens Financial Group Inc. RI raised its holdings in Cooper Companies by 2.7% in the 3rd quarter. Citizens Financial Group Inc. RI now owns 7,181 shares of the medical device company’s stock valued at $492,000 after buying an additional 192 shares during the period. Finally, State of Michigan Retirement System lifted its position in Cooper Companies by 0.4% in the second quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock valued at $3,867,000 after buying an additional 200 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.